Mark Perry

Mark Perry is an experienced executive and attorney who currently serves as an independent director at MyoKardia. Mark has held numerous leadership positions over the course of their career, including President and CEO of Aerovance, Inc. and Executive Officer at Gilead Sciences. Prior to their work in the private sector, Perry was an attorney at Cooley LLP. Mark has a long history of success in both legal and business settings, and brings a wealth of knowledge and experience to their current role at MyoKardia.

Mark Perry began their educational career at the University of California, Berkeley, where they earned their Bachelor of Arts (B.A.) degree. Mark then went on to attend the University of California, Davis - School of Law, where they earned their Doctor of Law (JD) degree.